The Sonalleve MR-HIFU (MR-guided High Intensity Focused Ultrasound) fibroid therapy system, by Philips, offers a non-invasive treatment for uterine fibroids. It combines the power of two modalities by integrating an advanced high intensity focused ultrasound system into the patient table of the Achieva MR system. It uses focused ultrasound waves to heat and coagulate tissue deep inside the body without damaging intervening tissue, and combines this with advanced planning, guidance and temperature monitoring provided by MR. The procedure can be performed on an outpatient basis, with an almost full recovery within a few days.
If you enjoy this content, please share it with a colleague
Related Content
March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...
March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...
March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...
March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...
March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...
Feb. 26, 2026 — AS Software, a provider of specialty-focused ultrasound reporting solutions, has announced that the U.S ...
Feb. 25, 2026 — GE HealthCare is introducing the next generation of LOGIQ general imaging ultrasound systems – an ...
Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...
Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...
Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...
March 13, 2026 